pemafibrate
Kowa Pharmaceuticals
[]
prominent trial of tg lowering in dm2 pts with dyslipidemia fails to show a benefit. correlation causation. time to stop using fibrates?
#aha22 
Asst Prof @harvardmed | Multimodality Cardiac Imager | Director #EchoFirst Lab @BIDMC | Researcher @SmithBIDMC | Ex-BOD @ASE360 | Tweets ? endorsement